Browsing by Author Gordon, J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 10 of 10
TitleAuthor(s)Issue date
ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular processHolden, N. J.; Williams, J. M.; Morgan, M. D.; Challa, A.; Gordon, J.; Pepper, R. J.; Salama, A. D.; Harper, L.; Savage, C. O.24-Nov-2015
CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cellsStewart, R.; Wei, W.; Challa, A.; Armitage, R. J.; Arrand, J. R.; Rowe, M.; Young, L. S.; Eliopoulos, A.; Gordon, J.24-Nov-2015
CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxinGordon, J.; Challa, A.; Levens, J. M.; Gregory, C. D.; Williams, J. M.; Armitage, R. J.; Cook, J. P.; Roberts, L. M.; Lord, J. M.24-Nov-2015
CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40Gagro, A.; McCloskey, N.; Challa, A.; Holder, M.; Grafton, G.; Pound, J. D.; Gordon, J.24-Nov-2015
Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cellsJarvis, R. M.; Chamba, A.; Holder, M. J.; Challa, A.; Smith, D. C.; Hodgkin, M. N.; Lord, J. M.; Gordon, J.24-Nov-2015
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell deathWasik, A. M.; Gandy, M. N.; McIldowie, M.; Holder, M. J.; Chamba, A.; Challa, A.; Lewis, K. D.; Young, S. P.; Scheel-Toellner, D.; Dyer, M. J.; Barnes, N. M.; Piggott, M. J.; Gordon, J.24-Nov-2015
Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis in human B cellsChalla, A.; Pound, J. D.; Armitage, R. J.; Gordon, J.24-Nov-2015
Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cellsPound, J. D.; Challa, A.; Holder, M. J.; Armitage, R. J.; Dower, S. K.; Fanslow, W. C.; Kikutani, H.; Paulie, S.; Gregory, C. D.; Gordon, J.24-Nov-2015
Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40Jacob, A.; Pound, J. D.; Challa, A.; Gordon, J.24-Nov-2015
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropicsMeredith, E. J.; Holder, M. J.; Chamba, A.; Challa, A.; Drake-Lee, A.; Bunce, C. M.; Drayson, M. T.; Pilkington, G.; Blakely, R. D.; Dyer, M. J.; Barnes, N. M.; Gordon, J.24-Nov-2015